Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR2 | P50052 | 13/20 | 0.37 |
| ▸ | AGTR1 | P30556 | 4/20 | 0.36 |
| ▸ | PPARG | P37231 | 3/20 | 0.36 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4553762 | 0.94 | AGTR2 (0.37) | AGTR2AGTR1PPARGMCL1 | |
| SCHEMBL4555122 | 0.93 | MAPK8 (0.37) | PLA2G4AMCL1 | |
| SCHEMBL4554828 | 0.91 | AGTR2 (0.38) | AGTR2AGTR1PPARGPLA2G4AMCL1 | |
| SCHEMBL4554438 | 0.89 | MAPK8 (0.35) | AGTR2PPARGPLA2G4AMCL1 | |
| SCHEMBL4553883 | 0.87 | SMN1; SMN2 (0.33) | PPARGPLA2G4AMCL1 | |
| SCHEMBL4553444 | 0.87 | SMN1; SMN2 (0.44) | PPARGPLA2G4AMCL1 | |
| SCHEMBL964454 | 0.87 | PPARG (0.42) | PPARG | |
| SCHEMBL4554652 | 0.86 | GABRA1 (0.36) | AGTR2PLA2G4AMCL1 | |
| SCHEMBL4570493 | 0.86 | PHGDH (0.36) | PLA2G4AMCL1 | |
| SCHEMBL964880 | 0.86 | TP53 (0.37) | PPARGPLA2G4AMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2118066-A1 | FUSED RING COMPOUNDS AS PARTIAL AGONISTS OF PPAR-GAMMA | Takeda Pharmaceutical Company Limited (JP) | 2009-11-18 | — | — | EP | disclosed |
| WO-2008099794-A1 | FUSED RING COMPOUNDS AS PARTIAL AGONISTS OF PPAR-GAMMA | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-08-21 | — | — | WO | disclosed |